Despite strong homology with the smMLCK promoter (~90%), the MYLKP1 promoter is minimally active in normal bronchial epithelial cells but highly active as the smMLCK promoter in lung adenocarcinoma cells. Here, MYLK is linked to lung adenocarcinoma.